Clinical Case Series - 23MM1 - Question 1

Which option do you typically consider for your patients with heavily pretreated MM?

Best supportive care
Rechallenge using different combinations of previously used agents to which the patient had a prior good response
Consider the use of a medication with a novel mechanism of action, such as teclistamab, or a clinical trial
Consider chimeric antigen receptor (CAR) T-cell therapy
{"name":"Clinical Case Series - 23MM1 - Question 1", "url":"https://www.poll-maker.com/QWZ9LADHP","txt":"Which option do you typically consider for your patients with heavily pretreated MM?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys